Experience sampling and ecological momentary assessment studies in psychopharmacology: A systematic review

European Neuropsychopharmacology

Volumn 25, Issue 11, 2015, Pages 1853-1864

  Bos, Fionneke M ^a   Schoevers, Robert A ^b   aan het Rot, Marije ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Affect; Ecological momentary assessment; Experience sampling; Personalized medicine; Processes of change; Treatment

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMPHETAMINE; AMPHETAMINE PLUS DEXAMPHETAMINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATOMOXETINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; ESCITALOPRAM; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; LISDEXAMFETAMINE; MEMANTINE; METHYLPHENIDATE; NALTREXONE; NICOTINE GUM; NICOTINE PATCH; OLANZAPINE; PLACEBO; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

AFFECT; ALCOHOLISM; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR ASSESSMENT; COGNITIVE THERAPY; DATA BASE; DSM-III-R; DSM-IV; ECOLOGICAL MOMENTARY ASSESSMENT; EMOTION; EXPERIENCE SAMPLING; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL PATIENT; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PERSONAL EXPERIENCE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; REWARD; SAMPLING; SCHIZOPHRENIA; SMOKING CESSATION; STRESS; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT RESPONSE; MENTAL DISORDERS; PROCEDURES; PSYCHOLOGIC TEST;

HUMANS; MENTAL DISORDERS; PRECISION MEDICINE; PSYCHOLOGICAL TESTS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS;

EID: 84947492753     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.08.008     Document Type: Review

References (56)

1. aan het Rot M., Hogenelst K., Schoevers R.A. Mood disorders in everyday life: a systematic review of experience sampling and ecological momentary assessment studies. Clin. Psychol. Rev. 2012, 32:510-523.
2. aan het Rot M., Moskowitz D.S., Pinard G., Young S.N. Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals. J. Psychiatry Neurosci. 2006, 31:253-262.
3. aan het Rot M., Zarate C.A., Charney D.S., Mathew S.J. Ketamine for depression: where do we go from here?. Biol. Psychiatry 2012, 72:537-547.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Publishing.
5. Barclay-Goddard R., Epstein J.D., Mayo N.E. Response shift: a brief overview and proposed research priorities. Q. Life Res 2009, 18:335-346. An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation.
6. Barge-Schaapveld D., Nicolson N.A. Effects of antidepressant treatment on the quality of daily life: an experience sampling study. J. Clin. Psychiatry 2002, 63:477-485.
7. Barge-Schaapveld D., Nicolson N.A., van d.H., DeVries M.W. Changes in daily life experience associated with clinical improvement in depression. J. Affect. Disord. 1995, 34:139-154.
8. Brown L.H., Strauman T., Barrantes-Vidal N., Silvia P.J., Kwapil T.R. An experience-sampling study of depressive symptoms and their social context. J. Nerv. Ment. Dis. 2011, 199:403-409.
9. Bruining N., Caiani E., Chronaki C., Guzik P., van der Velde E. Acquisition and analysis of cardiovascular signals on smartphones: potential, pitfalls and perspectives: by the task force of the e-Cardiology Working Group of the European Society of Cardiology. Eur. J. Prev. Cardiol. 2014, 21:4-13.
10. Conner T.S., Lehman B.J. Getting started: launching a study in daily life 2012, 89-107. Guilford Press, New York, NY US. M.R. Mehl, T.S. Conner (Eds.).
11. Cooney N.L., Litt M.D., Cooney J.L., Pilkey D.T., Steinburg H.R., Oncken C.A. Alcohol and tobacco cessation in alcohol-dependent smokers: analysis of real-time reports. Psychol. Addict. Behav. 2007, 21:277-286.
12. Food and Drug Administration Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed. Regist. 2009, 74:65132-65133.
13. Forbes E.E., Stepp S.D., Dahl R.E., Ryan N.D., Whalen D., Axelson D.A., Birmaher B., Silk J.S. Real-world affect and social context as predictors of treatment response in child and adolescent depression and anxiety: an ecological momentary assessment study. J. Child Adolesc. Psychopharmacol. 2012, 22:37-47.
14. Gehricke J., Hong N., Wigal T.L., Chan V., Doan A. ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD. Pharmacol. Biochem. Behav. 2011, 98:485-491.
15. Gehricke J., Whalen C.K., Jamner L.D., Wigal T.L., Steinhoff K. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: a preliminary examination. Nicotin Tob. Res. 2006, 8:37-47.
16. Geschwind N., Nicolson N.A., Peeters F., van Os J., Barge-Schaapveld D., Wichers M. Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. Eur. Neuropsychopharmacol. 2011, 21:241-247.
17. Gwaltney C.J., Shields A.L., Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 2008, 11:322-333.
18. Haedt-Matt A., Keel P.K. Hunger and binge eating: a meta-analysis of studies using ecological momentary assessment. Int. J. Eat. Disord. 2011, 44:573-578.
19. Hamaker E.L. Why researchers should think 'within-person': a paradigmatic rationale 2012, 43-61. Guilford Press, New York, NY, US. M.R. Mehl, T.S. Conner (Eds.).
20. Heron K.E., Smyth J.M. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br. J. Health Psychol. 2010, 15:1-39.
21. Höhn P., Menne-Lothmann C., Peeters F., Nicolson N.A., Jacobs N., Derom C., Thiery E., van Os J., Wichers M. Moment-to-moment transfer of positive emotions in daily life predicts future course of depression in both general population and patient samples. PLoS One 2013, 8. e75655.
22. Holt L.J., Litt M.D., Cooney N.L. Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment. Psychol. Addict. Behav. 2012, 26:561-572.
23. Hufford M.R., Shields A.L. Electronic diaries: applications and what works in the field. Appl. Clin. Trials 2002, 11:46-56.
24. Intille S.S. Emerging Technology for Studying Daily Life. Emerging Technology for Studying Daily Life 2012, 267-282. Guilford Press, New York, NY, US. M.R. Mehl, T.S. Conner (Eds.).
25. Kashdan T.B., Farmer A.S. Differentiating emotions across contexts: comparing adults with and without social anxiety disorder using random, social interaction, and daily experience sampling. Emotion 2014, 14:629-638.
26. Koster E.H.W., De Raedt R., Leyman L., De Lissnyder E. Mood-congruent attention and memory bias in dysphoria: exploring the coherence among information-processing biases. Behav. Res. Ther. 2010, 48:219-225.
27. Kramer I., Simons C.J.P., Hartmann J.A., Menne-Lothmann C., Viechtbauer W., Peeters F., Schruers K., van Bemmel A.,L., Myin-Germeys I., Delespaul P., van Os J., Wichers M. A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry 2014, 13:68-77.
28. Lataster J., Myin-Germeys I., Wichers M., Delespaul P.A.E.G., van Os J., Bak M. Psychotic exacerbation and emotional dampening in the daily life of patients with schizophrenia switched to aripiprazole therapy: a collection of standardized case reports. Ther. Adv. Psychopharmacol. 2011, 1:145-151.
29. Lataster J., van Os J., de Haan L., Thewissen V., Bak M., Lataster T., Lardinois M., Delespaul P.A.E.G., Myin-Germeys I. Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study. J. Clin. Psychiatry 2011, 72:1397-1404.
30. Lenderking W.R., Hu M., Tennen H., Cappelleri J.C., Petrie C.D., Rush A.J. Daily process methodology for measuring earlier antidepressant response. Contemp. Clin. Trials 2008, 29:867-877.
31. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339. b2535.
32. Molenaar P.C.M. A manifesto on psychology as idiographic science: bringing the person back into scientific psychology, this time forever. Meas. Interdisciplin. Res. Perspect. 2004, 2:201-218.
33. Moskowitz D.S., Sadikaj G. Event-contingent recording 2012, 160-175. Guilford Press, New York, NY, US. M.R. Mehl, T.S. Conner (Eds.).
34. Moskowitz D.S., Young S.N. Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology. J. Psychiatry Neurosci. 2006, 31:13-20.
35. Muhonen L.H., Lahti J., Sinclair D., Lönnqvist J., Alho H. Treatment of alcohol dependence in patients with co-morbid major depressive disorder-Predictors for the outcomes with memantine and escitalopram medication. Subst. Abuse Treat. Prev. Policy 2008, 3.
36. Myin-Germeys I. Psychiatry 2012, 636-650. Guilford Press, New York, NY, US. M.R. Mehl, T.S. Conner (Eds.).
37. Oorschot M., Kwapil T., Delespaul P., Myin-Germeys I. Momentary assessment research in psychosis. Psychol. Assess. 2009, 21:498-505.
38. Peeters F., Berkhof J., Rottenberg J., Nicolson N.A. Ambulatory emotional reactivity to negative daily life events predicts remission from major depressive disorder. Behav. Res. Ther. 2010, 48:754-760.
39. Reis H.T. Why researchers should think 'real-world': a conceptual rationale 2012, 3-21. Guilford Press, New York, NY, US. M.R. Mehl, T.S. Conner (Eds.).
40. Roth T., Mayleben D., Corser B.C., Singh N.N. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. Hum. Psychopharmacol. Clin. Exp. 2008, 23:13-20.
41. Sheehan D.V., Sheehan K.H., Raj B.A. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder. Psychopharmacol. Bull. 2007, 40:63-81.
42. Shiffman S. Ecological momentary assessment (EMA) in studies of substance use. Psychol. Assess. 2009, 21:486-497.
43. Solhan M.B., Trull T.J., Jahng S., Wood P.K. Clinical assessment of affective instability: comparing EMA indices, questionnaire reports, and retrospective recall. Psychol. Assess. 2009, 21:425-436.
44. Stone A.A., Shiffman S., Schwartz J.E., Broderick J.E., Hufford M.R. Patient non-compliance with paper diaries. BMJ 2002, 324:1193-1194.
45. Tidey J.W., Monti P.M., Rohsenow D.J., Gwaltney C.J., Miranda R.J., McGeary J.E., MacKillop J., Swift R.M., Abrams D.B., Shiffman S., Paty J.A. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol. Clin. Exp. Res. 2008, 32:58-66.
46. Vermeeren A., Vuurman E.F.P.M., Leufkens T.R.M., Van Leeuwen C.,J., Van Oers A.,C.M., Laska E., Rico S., Steinberg F., Roth T. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use. Sleep 2014, 37:489-496.
47. Walz L.C., Nauta M.H., aan het Rot M. Experience sampling and ecological momentary assessment for studying the daily lives of patients with anxiety disorders: a systematic review. J. Anxiety Disord. 2014, 28:925-937.
48. Watson D., Clark L.A., Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54:1063-1070.
49. Whalen C.K., Henker B., Ishikawa S.S., Emmerson N.A., Swindle R., Johnston J.A. Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study. J. Atten. Disord. 2010, 13:391-400.
50. Whalen C.K., Henker B., Jamner L.D., Ishikawa S.S., Floro J.N., Swindle R., Perwien A.R., Johnston J.A. Toward mapping daily challenges of living with ADHD: maternal and child perspectives using electronic diaries. J. Abnorm. Child Psychol. 2006, 34:115-130. An official publication of the International Society for Research in Child and Adolescent Psychopathology.
51. Wichers M.C., Barge-Schaapveld D., Nicolson N.A., Peeters F., de Vries M., Mengelers R., van Os J. Reduced stress-sensitivity or increased reward experience: the psychological mechanism of response to antidepressant medication. Neuropsychopharmacology 2009, 34:923-931.
52. Wichers M.C., Hartmann J.A., Kramer I.M.A., Lothman C., Peeters F., van Bemmel L., Myin-Germeys I., Delespaul P., van Os J., Simons C.J.P. Translating assessments of the film of daily life into person-tailored feedback interventions in depression. Acta Psychiatr. Scand. 2011, 123:402-403.
53. Wichers M.C., Lothmann C., Simons C.J.P., Nicolson N.A., Peeters F. The dynamic interplay between negative and positive emotions in daily life predicts response to treatment in depression: a momentary assessment study. Br. J. Clin. Psychol. 2012, 51:206-222.
54. Wichers M.C., Simons C.J.P., Kramer I.M.A., Hartmann J.A., Lothmann C., Myin-Germeys I., van Bemmel A.L., Peeters F., Delespaul P., van Os J. Momentary assessment technology as a tool to help patients with depression help themselves. Acta Psychiatr. Scand. 2011, 124:262-272.
55. Wilhelm P., Perrez M., Pawlik K. Conducting research in daily life: a historical review 2012, 62-86. Guilford Press, New York, NY US. M.R. Mehl, T.S. Conner (Eds.).
56. Young S.N., Moskowitz D.S., aan het Rot M. Possible role of more positive social behaviour in the clinical effect of antidepressant drugs. J. Psychiatry Neurosci. 2014, 39:60-65.